GRCE
Grace Therapeutics Inc.

27,644
Mkt Cap
$55.86M
Volume
51,592.00
52W High
$3.94
52W Low
$1.75
PE Ratio
-10.02
GRCE Fundamentals
Price
$3.61
Prev Close
$3.53
Open
$3.56
50D MA
$3.53
Beta
1.06
Avg. Volume
124,281.50
EPS (Annual)
-$0.7916
P/B
0.86
$5.43
Loading...
Loading...
News
all
press releases
Grace Therapeutics (NASDAQ:GRCE) Announces Earnings Results
Grace Therapeutics (NASDAQ:GRCE - Get Free Report) posted its earnings results on Thursday. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Grace Therapeutics (GRCE) Expected to Announce Quarterly Earnings on Thursday
Grace Therapeutics (NASDAQ:GRCE) will be releasing its Q3 2026 earnings before the market opens on Thursday, February 12. (View Earnings Report at...
MarketBeat·10d ago
News Placeholder
Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Up 34.6% in January
Grace Therapeutics, Inc. (NASDAQ:GRCE - Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totaling...
MarketBeat·13d ago
News Placeholder
Grace Therapeutics, Inc. (NASDAQ:GRCE) Sees Significant Increase in Short Interest
Grace Therapeutics, Inc. (NASDAQ:GRCE - Get Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 31,816 shares...
MarketBeat·28d ago
News Placeholder
Grace Therapeutics, Inc. (NASDAQ:GRCE) Sees Significant Growth in Short Interest
Grace Therapeutics, Inc. (NASDAQ:GRCE - Get Free Report) was the target of a large increase in short interest in December. As of December 15th, there was short interest totaling 24,289 shares, an...
MarketBeat·2mo ago
<
...
1
>

Latest GRCE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.